<div id="readability-page-1">Charles Schwab’s chief investment strategist Liz Ann Sonders expects the market to continue broadening beyond top performers in 2026. In an interview by CNBC, Sonders noted that while only 17% of S&amp;P 500 (SP500) constituents outperformed the index six months ago, that figure has recently jumped to 61%, signaling improving market breadth. She also h...</div>

KROS

NUTX

INVA

<p>查尔斯·施瓦布的 Liz Ann Sonders 预测，2026 年市场将超越大型股，向更广泛的领域发展，小型股将显示出改善。她建议关注小型股中盈利能力强的细分市场，强调 Nutex Health、IRSA、Power Solutions、Amerigo Resources、Innoviva 和 Keros Therapeutics 作为首选。尽管经济指标放缓，盈利仍在推动市场表现。Sonders 建议选择性投资于高质量、盈利的股票，以获得更好的回报</p>

嘉信理财的 Liz Ann Sonders 表示，股票将在 2026 年继续扩展至大盘股之外